Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Journal of Clinical Oncology (JCO)
Published October 26, 2026
Dalmelitinib Plus Aumolertinib in Advanced NSCLC Patients With EGFR-TKI Resistance and MET Amplif...
October 26, 2026
Medspoke
Medspoke
Journal of Clinical Endocrinology & Metabolism (JCEM)
Published October 26, 2026
00:00
--:--
Efficacy and Safety of Lonapegsomatropin in Children With Turner Syndrome: 52-Week Results From t...
October 26, 2026
Share
Efficacy and Safety of Lonapegsomatropin in Children With Turner Syndrome: 52-Week Results From the New InsiGHTS Trial.
https://www.medspoke.co/channel_journal?id=680&tap_id=16327
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Kidney International Reports
Published September 25, 2026
Urinary Peptidomic Signature for Noninvasive Diagnosis of Alport Syndrome in Children.
October 26, 2026
Why are you reporting this TALK?
